Ivonne Jimenez Velazquez, MD
Geriatric Medicine · Carolina, PRNPI 1407974546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 39.5% of the total.
Across 31 payments — averaging $43.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$536
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$200
- Eisai Inc.$125
- Johnson & Johnson$121
- E.r. Squibb & Sons, L.L.C.$97
- Lilly USA, LLC$87
- plus $192 from 4 others
Across 32 payments — averaging $8878.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$262K
- E.r. Squibb & Sons, L.L.C.$15K
- Eli Lilly$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
What the payments were for
- Food & beverage$1,358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $536 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $200 |
| Eisai Inc. | 1 | $125 |
| Johnson & Johnson | 2 | $121 |
| E.r. Squibb & Sons, L.L.C. | 1 | $97 |
| Lilly USA, LLC | 1 | $87 |
| F. Hoffmann-la Roche AG | 1 | $80 |
| Rhythm Pharmaceuticals, Inc. | 1 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,358 in reported general payments places this provider in the 85th percentile of 76 geriatric medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SprycelDasatinib | 11 | $113,601 |
| EliquisApixaban | 20 | $14,008 |
| SynthroidLevothyroxine Sodium | 114 | $9,910 |
| Rivastigmine | 26 | $4,900 |
| Sucralfate | 16 | $1,978 |
| Memantine Hcl | 64 | $1,875 |
| Memantine Hcl ErMemantine Hcl | 22 | $1,797 |
| Candesartan Cilexetil | 12 | $1,453 |
| Gabapentin | 77 | $1,244 |
| Mirtazapine | 21 | $1,187 |
| Donepezil Hcl | 54 | $1,133 |
| Rosuvastatin Calcium | 67 | $1,128 |
| Losartan Potassium | 99 | $1,116 |
| Atorvastatin Calcium | 80 | $869 |
| Escitalopram Oxalate | 47 | $765 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Sprycel | $97 | $113,60111 claims |
| AbbVieSynthroid | $536 | $9,910114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 76 geriatric medicine providers in Puerto Rico.
Other geriatric medicine in Carolina
- Luz Acevedo-VargasCarolina$638
- Jose Camunas-ColonCarolina$493
- Eileen OrtegaCarolina$353
- Michel Santiago-BerriosCarolina$347
- Milagros Florian GermanCarolina$306
- Ismenio Millan AponteCarolina$288
- Javier Anaya GonzalezCarolina$84
- Ubaldo Santiago BuonoSan Juan$5K
- Ismael Toro GrajalesBayamon$5K
- Antolin PadillaGuaynabo$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.